Linkedin Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Tuesday, October 20, 2026, 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.

Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.

Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.

Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.

Webinar presenter Jeffrey Gregg, MD, University of Nevada

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.

Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Marketplace

Handheld label printer, 7/14

July 2014—Combining a tough exterior with smart printing capabilities, Brady’s BMP21-LAB handheld printer is designed for labeling slides, straws, dishware, bottles, vials, and tubes. The printer’s drop, lock, and print technology enables users to insert the label cartridge and start printing, with no setup required. The vial label shortcut key automatically cuts labels according to vial and tube sizes. Once the label is printed and cut, the grabber feature prevents it from falling to the ground.

Preanalytical sample processing instrument, 7/14

July 2014—Hologic’s Tomcat instrument performs a full range of sample processing activities for liquid-based cytology samples, from decapping and capping of sample tubes to vortexing, aliquoting, incubating, and racking of each sample. The fully automated instrument provides positive bar-code matching for each sample as well as reagent addition if desired. By eliminating repetitive manual steps, the instrument enhances workflow efficiency and reduces hands-on time, which minimizes the risk of cross-contamination.

DeNovo Sciences publishes on CTC technology, 7/14

July 2014—DeNovo Sciences published “A novel microchannel-based device to capture and analyze circulating tumor cells (CTCs) of breast cancer.” DeNovo’s scientific team explored microfluidic capture techniques for isolating CTCs, which resulted in the development of proprietary technology to accomplish rare cell capture and analysis.

Combined urinalysis control, 6/14

June 2014—Streck introduced UA-Cellular Complete, a urinalysis control with both chemistry analytes and cellular components to more closely mimic a patient sample.

Rapid HIV tests, 6/14

June 2014—Chembio will begin marketing and selling the FDA-approved and CLIA-waived Chembio HIV 1/2 STAT-PAK assay in the U.S. market.

Beckman Coulter to acquire Xitogen, 6/14

June 2014—Beckman Coulter entered into an agreement to acquire Xitogen Technologies together with Cytojene Corp. Xitogen, a flow cytometer developer based in Suzhou and Dalian, China, will provide Beckman Coulter Life Sciences with an operational base in the China market, and the facilities in Suzhou and Dalian will function as research and development and manufacturing centers.

Influenza type A and B kit, 6/14

June 2014—The Poly stat Flu A & B kit from Polymedco is an in vitro, rapid qualitative test that detects influenza type A and B, including numerous strains of H1N1, directly from a nasal or nasopharyngeal swab, as well as nasopharyngeal aspirate/wash specimens.

Molecular subtyping with Agendia tests, 6/14

June 2014—Research presented at the annual conference of the American Society of Breast Surgeons in May reported that molecular subtyping using Agendia’s MammaPrint and BluePrint tests can provide guidance about whether to propose neoadjuvant treatment and what kind of treatment to recommend.

High-performance rotors, 6/14

June 2014—Designed for applications that use common, disposable conical tubes, JA-14.50 rotors from Beckman Coulter extend the applications and flexibility of the company’s Avanti centrifuges.

epMotion for TruSeq, 6/14

June 2014—Eppendorf announced the epMotion automation method for Illumina’s TruSeq Stranded Total RNA library preparation kit for next-generation sequencing as “Illumina Qualified.”

MARKETPLACE

TRENDING